Mouse IgG2a Isotype Control – Purified in vivo PLATINUM™ Functional Grade

Mouse IgG2a Isotype Control – Purified in vivo PLATINUM™ Functional Grade

Product No.: P381

[product_table name="All Top" skus="P381"]

- -
- -
Product. No.P381
Clone
C1.18.4
Antibody Type
Isotype Control
Isotype
Mouse
Mouse IgG2a k

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Host Species
Mouse
Recommended Dilution Buffer
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
<0.5 EU/mg as determined by the LAL method
Purity
≥98% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
This Mouse IgG2a isotype control is a monoclonal antibody and has been tested against selected species' cells and tissues to assure minimal cross reactivity.

References & Citations

1. Ikeda Y. et al. (2003) Blood.101(2):621-3. Article Link
2. Wright, TM et al. (2000) J Immunol.164(12):6138-46.PubMed
3. Wright, TM et al. (2001) Arthritis Rheum. 44(7):1654-9. PubMed
4. Nishikawa, Takeji et al. (2000) Journal of Investigative Dermatology 114(1): 88-94. PubMed
Flow Cytometry
in vivo Protocol

Certificate of Analysis

- -
- -
Prod No.
Description
T706
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.